AAPS PharmSci 360 covers the essential role of basic research in laying the scientific foundation for applied science. It drives new ideas, innovations, and advancements in therapeutic development, accelerating the creation of tools and the delivery of novel drugs to the market.
Alicia Bian, Principal Scientist, Method Development, is presenting poster “Innovative SISCAPA-LC-MS/MS Quantitation of a Neurological Disorder Biomarker in CSF: Bridging Immunoassays & Mass Spectrometry with Worldwide BioA Expertise“.
Swing by for Happy Hour and create your own margarita—right next to booth 2535 on Monday, November 10, 3–5 PM CDT.
Worldwide Clinical Trials welcomes you to our site. We collect information about your browsing experience such as cookies, pixels, and web beacons (collectively, “cookies”) to assist with improving your experience with our website. You may ‘Agree’ to accept categories of cookies or ‘Decline’ to reject optional cookies. Worldwide uses Essential Cookies, thus you may not opt of these Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For additional information on the categories of data we collect, the purposes for their collection, disclosures to third parties, and data retention, please visit our Privacy Policy or Cookie Notice for more information.